Espey Manufacturing & Electronics is one of the market's purer plays on military power electronics, a 98-year-old original equipment manufacturer that designs and builds the power supplies, converters, transformers, and magnetics that feed electricity to radar systems, naval vessels, locomotives, and ground vehicles. The stock has had a steep run in the range sense, trading at $63.08 against a 52-week span of $36.00 to $74.77, and the market now assigns the company a market capitalization of roughly $177 million, a trailing price-to-earnings multiple of 17.0x, and a dividend yield of 1.54%. The question the stock forces is whether the margin transformation visible in fiscal 2026 is durable enough to support that valuation, or whether Espey is benefiting from a temporary mix of mature, high-margin programs that a soft order book will eventually erode.
What changed this year is profitability, not volume. For the nine months ended March 31, 2026, fiscal Q3 of Espey's June-based fiscal year, net sales actually declined 5% to $32.65 million from $34.35 million. Yet gross margin expanded from 25.9% to 35.7% over the same stretch, and the third quarter alone delivered a 37.0% gross margin against 28.6% a year earlier. Nine-month net income jumped 50% to $7.84 million, or $2.74 per diluted share, from $5.21 million, or $1.95. The driver is mix: shipments are shifting toward mature production programs and build-to-print work, which carry structurally higher margins than the engineering development contracts where Espey deliberately invests at a loss to win future production tails. Management has guided that full-year fiscal 2026 revenue and net income will both exceed fiscal 2025, which implies a strong fourth quarter.
The strongest evidence supporting the constructive case sits on the balance sheet. Total backlog stands at $137.1 million, roughly three times the company's annual revenue run rate, and it is fully funded except for $14.5 million. Beyond backlog, Espey disclosed approximately $152.5 million in outstanding opportunities as of May 7, 2026, a pipeline of bids and expected awards covering both repeat and new programs. The balance sheet carries no debt, working capital grew to $50.5 million, and the company is generating enough interest income to contribute meaningfully to the bottom line.
The most important counterargument is the order rate. New orders in the first nine months of fiscal 2026 were just $30 million, down from $75.1 million a year earlier, and fiscal 2025's $86.4 million order intake was inflated by two multi-year awards totaling $49.4 million that are unlikely to repeat. Backlog has drifted down slightly year over year, from $138 million. If the $152.5 million pipeline converts poorly, today's margin-rich revenue mix eventually rolls off into a thinner one, and at 17 times trailing earnings the stock has little cushion for that outcome.
The forward variable that decides between these scenarios is pipeline conversion, visible in quarterly order announcements over the next two to three quarters. On valuation, the trailing multiple looks undemanding if the fiscal 2026 earnings guidance holds, since annualized nine-month earnings already approximate the implied trailing figure, but it is demanding relative to a flat-to-declining order book. Espey is a profitable, debt-free defense niche manufacturer trading at a reasonable multiple; the debate is entirely about whether the order funnel refills fast enough to keep the margin story alive into fiscal 2027.